Yang W - Search Results

1

Cytoplasmic FBXO38 mediates PD-1 degradation.

Liu X, Meng X, Lin Z, Jiang S, Liu H, Sun SC, Liu X, Zhou P, Huang X, Wei L, Yang W, Xu C. Liu X, et al. Among authors: yang w. EMBO Rep. 2024 Oct;25(10):4168-4171. doi: 10.1038/s44319-024-00254-y. Epub 2024 Sep 16. EMBO Rep. 2024. PMID: 39294504 Free PMC article.

2

Publisher Correction: Cytoplasmic FBXO38 mediates PD-1 degradation.

Liu X, Meng X, Lin Z, Jiang S, Liu H, Sun SC, Liu X, Zhou P, Huang X, Wei L, Yang W, Xu C. Liu X, et al. Among authors: yang w. EMBO Rep. 2024 Dec;25(12):5838. doi: 10.1038/s44319-024-00298-0. EMBO Rep. 2024. PMID: 39487370 Free PMC article.

3

Preliminary study on retinal vascular and oxygen-related changes after long-term silicone oil and foldable capsular vitreous body tamponade.

Yang W, Yuan Y, Zong Y, Huang Z, Mai S, Li Y, Qian X, Liu Y, Gao Q. Yang W, et al. Sci Rep. 2014 Jun 12;4:5272. doi: 10.1038/srep05272. Sci Rep. 2014. PMID: 24920425 Free PMC article.

4

Small Molecular-Sized Artesunate Attenuates Ocular Neovascularization via VEGFR2, PKCα, and PDGFR Targets.

Zong Y, Yuan Y, Qian X, Huang Z, Yang W, Lin L, Zheng Q, Li Y, He H, Gao Q. Zong Y, et al. Among authors: yang w. Sci Rep. 2016 Aug 2;6:30843. doi: 10.1038/srep30843. Sci Rep. 2016. PMID: 27480521 Free PMC article.

5

Elevated postoperative carcinoembryonic antigen guides adjuvant chemotherapy for stage II colon cancer: a multicentre cohort retrospective study.

Pu H, Yang W, Liu M, Pang X, Chen Y, Xiong Q. Pu H, et al. Among authors: yang w. Sci Rep. 2024 Mar 22;14(1):6889. doi: 10.1038/s41598-024-55967-w. Sci Rep. 2024. PMID: 38519578 Free PMC article.

6

Improving efficacy of TNBC immunotherapy: based on analysis and subtyping of immune microenvironment.

Yang Y, Li H, Yang W, Shi Y. Yang Y, et al. Among authors: yang w. Front Immunol. 2024 Oct 4;15:1441667. doi: 10.3389/fimmu.2024.1441667. eCollection 2024. Front Immunol. 2024. PMID: 39430759 Free PMC article. Review.

7

YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunity.

Zhang H, Luo X, Yang W, Wu Z, Zhao Z, Pei X, Zhang X, Chen C, Lei JH, Shi Q, Zhao Q, Chen Y, Wu W, Zeng Z, Ju HQ, Qiu M, Liu J, Shen B, Chen M, Chen J, Deng CX, Xu RH, Hou J. Zhang H, et al. Among authors: yang w. Nat Commun. 2024 Nov 5;15(1):9559. doi: 10.1038/s41467-024-53997-6. Nat Commun. 2024. PMID: 39500904 Free PMC article.

8

A Type IIb, but Not Type IIa, GnRH Receptor Mediates GnRH-Induced Release of Growth Hormone in the Ricefield Eel.

Chen D, Yang W, Han S, Yang H, Cen X, Liu J, Zhang L, Zhang W. Chen D, et al. Among authors: yang w, yang h. Front Endocrinol (Lausanne). 2018 Nov 30;9:721. doi: 10.3389/fendo.2018.00721. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30555419 Free PMC article.

9

The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer.

Li JJ, Wang JH, Tian T, Liu J, Zheng YQ, Mo HY, Sheng H, Chen YX, Wu QN, Han Y, Liao K, Pan YQ, Zeng ZL, Liu ZX, Yang W, Xu RH, Ju HQ. Li JJ, et al. Among authors: yang w. Nat Commun. 2023 Oct 23;14(1):6690. doi: 10.1038/s41467-023-42332-0. Nat Commun. 2023. PMID: 37872170 Free PMC article.

10

SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8⁺ T cell activation.

Liu W, You D, Lin J, Zou H, Zhang L, Luo S, Yuan Y, Wang Z, Qi J, Wang W, Ye X, Yang X, Deng Y, Teng F, Zheng X, Lin Y, Huang Z, Huang Y, Yang Z, Zhou X, Zhang Y, Chen R, Xu L, Li J, Yang W, Zhang H. Liu W, et al. Among authors: yang w, yang x, yang z. Cell Metab. 2024 Oct 1;36(10):2245-2261.e6. doi: 10.1016/j.cmet.2024.08.005. Epub 2024 Sep 6. Cell Metab. 2024. PMID: 39243758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33,936 results

Search Page

Filters